Ixiaro News
Most Popular Ixiaro Story
Novartis wins OK for new Japanese Encephalitis jab
The FDA has approved Novartis' application to market the vaccine Ixiaro to guard against Japanese Encephalitis, spurring speculation that the regulatory win might inspire Novartis to move to acquire Read more...
Latest Headlines
- Panel recommends Intercell's new Japanese encephalitis jabJune 25, 2009
- April 1, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
